These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Have we reached the point of no return? The hidden impact of antibacterial resistance in respiratory tract infection. Introduction. Craig WA Respir Med; 2001 Jun; 95 Suppl A():S2-4; discussion S26-7. PubMed ID: 11419670 [No Abstract] [Full Text] [Related]
8. [Comparative effectiveness of the strategies of etiotropic therapy of generalized chlamydia infections in young patients]. Pozniak AL; Lobzin IuV; Babkin PA Urologiia; 2000; (5):23-6. PubMed ID: 11392219 [No Abstract] [Full Text] [Related]
9. Therapeutic monitoring of antimicrobials: a summary of the information presented at the UK NEQAS for antibiotic Assays meeting for participants, October 1993. Reeves DS; MacGowan AP; Holt HA; Lovering AM; Warnock DW; White LO J Antimicrob Chemother; 1995 Jan; 35(1):213-26. PubMed ID: 7768771 [No Abstract] [Full Text] [Related]
17. Quinolones: which generation for which microbe? Lee MK; Kanatani MS West J Med; 1999 Jun; 170(6):359-61. PubMed ID: 10443165 [No Abstract] [Full Text] [Related]
18. [Antibiotics, developments and orientation]. de Marie S; Verbrugh HA Ned Tijdschr Geneeskd; 1992 Apr; 136(14):673-8. PubMed ID: 1560853 [No Abstract] [Full Text] [Related]
19. [New antibacterial agents]. Vaara M; Saxén H Duodecim; 1999; 115(20):2259-64. PubMed ID: 11973930 [No Abstract] [Full Text] [Related]
20. Quinolones and macrolides: roles in respiratory infections. Khan FA Hosp Pract (Off Ed); 1993 Jan; 28(1):149-153, 156-62. PubMed ID: 8380424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]